AOUI Verona

Verona, Veneto 37134

0 studies enrolling now · 7 studies all time

What they study most

Carcinoma, Transitional Cell, Endometriosis, Metastatic Colorectal Cancer, Neoplasms, Refractory and/or Unexplained Chronic Cough, Urothelial Carcinoma

Studies at this site

• ZN-c3 in Adult Participants With Metastatic Colorectal Cancer — Stopped early
• Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma — Completed
• Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb — Stopped early
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed
• Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough — Completed
• Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors — Completed
• Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis — Stopped early